+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Endothelin Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Endothelin Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 80 Pages
  • Global
From
Dilated Cardiomyopathy (DCM) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Dilated Cardiomyopathy (DCM) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 80 Pages
  • Global
From
Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Hypertension - Pipeline Insight, 2024

  • Drug Pipelines
  • December 2024
  • 240 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more